Jinyu Bio-technology Co., Ltd. (SHA:600201)

Jinyu Bio-technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,345	1,140	1,712	1,405	1,334	1,516
Trading Asset Securities	43.6	36.83	37.27	46.94	183.85	639.48
Cash & Short-Term Investments	1,389	1,176	1,749	1,452	1,518	2,156
Cash Growth	5.77%	-32.76%	20.46%	-4.32%	-29.58%	21.03%
Accounts Receivable	687.47	648.83	869.84	816.65	742.88	627.65
Other Receivables	65.26	45.14	44.37	57.29	41.49	36.04
Receivables	752.73	693.97	914.21	873.94	904.5	663.69
Inventory	252.59	294.64	322.25	333.46	317.65	350.66
Prepaid Expenses	-	3.49	3.45	-	1.07	1.07
Other Current Assets	114.57	22.93	26.51	20.91	19.4	16.08
Total Current Assets	2,509	2,191	3,016	2,681	2,761	3,187
Property, Plant & Equipment	1,911	1,830	1,892	1,799	1,819	1,720
Long-Term Investments	195.3	1,829	1,025	1,019	1,058	445.75
Goodwill	8.2	8.2	11.41	29.49	94.5	134.26
Other Intangible Assets	575.75	586.76	352.12	347.32	388.45	343.48
Long-Term Deferred Tax Assets	116.51	107.36	96.99	83.43	86.15	81.75
Long-Term Deferred Charges	61.87	69.84	378.12	322.53	260.16	238.7
Other Long-Term Assets	1,357	142.28	100.48	107.87	136.86	127.5
Total Assets	6,734	6,765	6,873	6,389	6,604	6,278
Accounts Payable	290.25	295.84	324.41	354.41	347.05	330.32
Accrued Expenses	27.53	58.85	76.96	101.36	102.82	79.99
Short-Term Debt	15.01	15.01	-	10.01	-	-
Current Portion of Leases	1.42	1.48	1.53	0.53	0.62	-
Current Income Taxes Payable	16.91	4.07	6.92	13.39	7.82	12.96
Current Unearned Revenue	81.69	105.14	98.38	84.65	82.55	80.36
Other Current Liabilities	297	244.67	332.25	94.39	148.29	175.9
Total Current Liabilities	729.8	725.06	840.45	658.75	689.15	679.53
Long-Term Leases	-	1.25	2.73	0.31	0.16	-
Long-Term Unearned Revenue	341.78	345.32	364.84	370.49	343.9	325.42
Long-Term Deferred Tax Liabilities	8.13	9.36	9.63	10.15	10.48	10.38
Other Long-Term Liabilities	2	268.29	-	-	-	-
Total Liabilities	1,082	1,349	1,218	1,040	1,044	1,015
Common Stock	1,112	1,120	1,120	1,120	1,126	1,126
Additional Paid-In Capital	736.79	764.9	891.52	834.3	893.34	886.67
Retained Earnings	3,873	3,693	3,673	3,456	3,366	3,119
Treasury Stock	-242.31	-209.67	-338.48	-338.48	-113.34	-150.02
Comprehensive Income & Other	-10.56	-53.9	20.46	-0.41	-0.23	-0.2
Total Common Equity	5,469	5,314	5,367	5,072	5,272	4,982
Minority Interest	183.83	101.04	288.06	277.45	287.98	281.28
Shareholders' Equity	5,653	5,415	5,655	5,350	5,560	5,263
Total Liabilities & Equity	6,734	6,765	6,873	6,389	6,604	6,278
Total Debt	16.43	17.74	4.27	10.85	0.78	-
Net Cash (Debt)	1,372	1,159	1,745	1,442	1,517	2,156
Net Cash Growth	4.79%	-33.61%	21.07%	-4.99%	-29.61%	23.82%
Net Cash Per Share	1.31	1.06	1.60	1.30	1.35	1.91
Filing Date Shares Outstanding	1,093	1,117	1,117	1,087	1,103	1,119
Total Common Shares Outstanding	1,093	1,117	1,117	1,087	1,103	1,119
Working Capital	1,779	1,466	2,175	2,022	2,071	2,507
Book Value Per Share	5.00	4.76	4.80	4.66	4.78	4.45
Tangible Book Value	4,885	4,719	5,003	4,695	4,789	4,504
Tangible Book Value Per Share	4.47	4.22	4.48	4.32	4.34	4.03
Buildings	-	1,274	1,153	1,152	1,128	1,040
Machinery	-	1,451	1,354	50.02	1,272	1,244
Construction In Progress	-	201.48	359.22	151.72	128.74	20.93

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.